Celltrion Healthcare IPO finally lifts off

The sales arm of drug maker Celltrion kicks off Korea's largest share sale this year hoping to match the success of other recent biopharma deals.

Celltrion Healthcare IPO finally lifts off

South Korea's Celltrion launched the domestic investor roadshow for a delayed W1 trillion $881 million initial public offering of its sales and distribution division on Monday, hoping to capitalise on robust investor sentiment towards biopharmaceutical IPOs.

Sources familiar with the situation said Celltrion Healthcare, which is headquartered in Incheon, has also begun to gauge interest from international investors ahead of an international roadshow starting July 3. Drugs group Celltrion aims to list...

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition